Raised circulating von Willebrand factor is a recognised marker of vascular injury.
ulcerative colitis, and 15/17 (p=00001) patients with bacterial diarrhoea. Serum von Willebrand factor was unrelated to disease activity in Crohn's disease but was significantly raised in active (p=0.02) compared with inactive ulcerative colitis. In contrast to controls, the detection of von Willebrand factor from inflammatory bowel disease sera and that from fractured endothelial cells was significantly inhibited by the reducing agent, dithiothreitol, suggesting the presence of an additional dithiothreitol sensitive form of the molecule derived from injured endothelial cells in inflammatory bowel disease. That serum von Willebrand factor is raised in quiescent as well as active Crohn's disease is compatible with the proposal that vascular injury is a fundamental abnormality in this disorder. The (Tables I and II) Crohn's disease (n=42; 14 with active and 28 inactive disease) and ulcerative colitis (n= 50; 23 with active and 27 with inactive disease) were diagnosed by conventional clinical, radiological, endoscopic, and histological criteria.
Disease activity in Crohn's disease was determined by Harvey's clinical index," with an additional 1 point for the following laboratory variables: haemoglobin <12 g/100 ml (men) and <11 g/100 ml (women); erythrocyte sedimentation rate >20 mm/hour; C reactive protein >08 MicroELISA plates (96 well) were coated with 100 ml of rabbit anti-human von Willebrand factor diluted 1/1000 in 0 05 mol/l carbonate buffer (pH 9-6) for one hour at room temperature. The plates were then washed in phosphate buffered saline (pH 7 4) containing 0 05% (v/v) Tween 20 (PBS-0-05% Tween), shaken dry, and 100 RI of a diluted standard or sample serum diluted 1/40 in PBS-0 1% Tween added to duplicate wells, and incubated at room temperature for one hour. PBS-0*1% Tween (100 tl) was also added to six microwells as blanks and a standard curve was determined for each plate by diluting (1/10-1/320) pooled healthy sera (the pooled serum standard had been previously confirmed to correspond to an NIBSC standard plasma for determination of von Willebrand factor. The plates were then washed three times by immersion into PBS-0-05% Tween (Table IV) , extent of disease in ulcerative colitis (Table III) , or drug treatments administered in either group. High concentrations of serum von Willebrand factor were also observed in 88% of patients with confirmed bacterial diarrhoea (p=00001).
Serial studies in inflammatory bowel disease patients showed no statistically significant differences in circulating von Willebrand factor when a change in disease activity occurred (Fig 2) . However, a fall in circulating von Willebrand factor accompanied the transition from active to inactive disease in 5 of 9 (p=NS) patients with ulcerative colitis. von Willebrand factor values also fell (p=00003) in all patients recovering from bacterial diarrhoea. No such trends were observed in patients with Crohn's disease, where a change from active to inactive disease was accompanied by a rise in serum von Willebrand factor in 7/9 patients.
SENSITIVITY OF VON WILLEBRAND FACTOR FROM INFLAMMATORY BOWEL DISEASE SERA TO DTT
Preincubation of sera with the reducing agent DTT (06-2A4 mmol/l) reduced, in a dose dependent manner, the amount of von Willebrand factor subsequently detected by ELISA (data not shown). Maximum inhibition by DTT, however, was related to the initial von Willebrand factor concentration: subjects with a raised concentration -that is, inflammatory bowel disease and bacterial diarrhoea patients -were more susceptible to inhibition than controls. A plot of the initial concentration against maximal inhibition by DTT (Fig 3) shows that a proportion of the von Willebrand factor measured by ELISA was completely resistant to the effects of DTT and that this proportion was greatest in subjects with normal serum von Willebrand factor concentrations. When von Willebrand factor released from fractured cells was tested for DTT sensitivity, the results were similar to those obtained from sera containing high concentrations (Fig 3) .
Discussion
Median serum von Willebrand factor concentrations were significantly raised in patients with Crohn's disease, ulcerative colitis, and bacterial diarrhoea compared with healthy controls. Serum concentrations were significantly higher in patients with active ulcerative colitis than those with inactive disease (Fig 1) . Furthermore, the transition from active to inactive disease in nine patients with ulcerative colitis was accom---.
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*~~~~p anied by a fall in von Willebrand factor in five of them (Fig 2) . The 
